Pirfenidon Prevents Experimental Flow-Associated PAH by Suppression of the NLRP3 Inflammasome von Mavrogiannis, E., Hagdorn, Q.A., Bazioti, V., Douwes, J.M., van der Feen, D.E., Oberdorf-Maass, S.U., Westerterp, M., Berger, R.M.

Volltext